15h-18h-Amphitéatre Deguit
Pôle Juridique et Judiciaire, place Pey Berland, 33000 Bordeaux.
Registration
https://sbm.u-bordeaux.fr/evenements/microbiota-seen-experts
Program
14h-Meeting with the SBMyoung group.
15h-Introduction: Mr le Directeur Général-CHU Mr Yann Bubien
Plenary talks: Microbiota view from international experts
(2 talks of 30 min each + 1 talk of 20 min)
-Pr Maria Gloria Dominguez Bello, Department of Biochemistry and Microbiology, Robert Wood Johnson Medical School, Rutgers university, New Jersey: “The human microbiome in the anthropocene.”
-Pr Martin J Blaser, Departments of Medicine and Pathology & Laboratory Medicine, RBHS, Robert Wood Johnson Medical School, Rutgers university, New Jersey: “The double-edged sword of antibiotics.”
-Pr Claire Andrejak, CHU de Amiens, service de Pneumologie:« Pulmonary Microbiote, what do we know (or don’t know) in 2022 ?”
Break: 30min
Symposium: « The microbiota in Bordeaux: crossed views of senior researchers »
(2 talks of 15 min each)
-Pr Maya Saleh, Immunoconcept, CNRS UMR 5164 – University of Bordeaux: « Exploring the role of the microbiome in patients response to cancer immunotherapies».
-Pr David Laharie, CHU de Bordeaux, service de gastroentérologie: « Deciphering host-microbiota crosstalk in acute severe ulcerative colitis »
Symposium: « The microbiota in Bordeaux: crossed views of young scientific researchers »
(4 talks of 10 min each)
– Marine Jauvain, INSERM U1312, BRIC, Team 4, University of Bordeaux and CHU de Bordeaux, Laboratoire de Bactériologie, CNR des Campylobacters et des Hélicobacters: Metformin modifies the gut microbiota of mice infected with Helicobacter pylori.
– Julie Giraud, Immunoconcept, CNRS UMR 5164 – University of Bordeaux: A role of intra-tumoral bacteria in HCC?
– Eléna Charpentier – Mycology department, Bordeaux CHU & Inserm U1045 : Mycobiota: An emerging component that FANCy helps to decipher by predicting the functional potential of a fungal community.
– Raphael Enaud – Paediatric CRCM, Bordeaux CHU & Inserm U1045: Impacts of CFTR modulators on the airway and gut mycobiota-microbiota in patients with cystic fibrosis.
Organizing committee: Pr L Delhaes, Pr C Roubaud Baudron, Dr E Bessède, Pr F Mégraud, Pr P Lehours.